ABBV to Acquire APGE
AbbVie is closing in on a nearly $11 billion deal to acquire biotech company Apogee Therapeutics
Reported Friday, 'AbbVie closes in on nearly $11bn deal for biotech Apogee Therapeutics' - FT
AbbVie is closing in on a nearly $11 billion deal to acquire biotech company Apogee Therapeutics
Reported Friday, 'AbbVie closes in on nearly $11bn deal for biotech Apogee Therapeutics' - FT